INVENT Endorsed RIVASVT-100 Pilot Study (Treatment of Splanchnic Vein Thrombosis With Rivaroxaban: A Pilot, Prospective Cohort Study) has 64 patients of 100 patients - as of January 2019. The study is expected to complete recruitment this spring/summer with 36 patients remaining to recruit and new Canadian sites participating in the international study.
For more information about the pilot study, please visit the clinical trials page.